NSEDisclosure under SEBI Takeover Regulations23 Jun 2026 · 23 Jun 2026, 04:07 pm

Disclosure under SEBI Takeover Regulations

Anthem Biosciences Limited · ANTHEM

✦ AI SummaryPledge

Anthem Biosciences Limited has received a disclosure from Ganesh Sambasivam regarding compliance with Regulations 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. These regulations primarily mandate disclosures related to creation, invocation, or release of encumbrances (pledges) on shares held by promoters or persons acting in concert. The announcement indicates a routine regulatory filing concerning changes in pledged share status.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

Full Announcement

Ganesh Sambasivam has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.